The Lexington, Mass.-based medical device company did not otherwise elaborate on the reason for Maggs’s departure, which was effective June 18, according to the filing.
Maggs joined GI Dynamics in April 2013 to oversee the clinical development of its EndoBarrier device, a gut liner designed to induce weight loss and help control diabetes in obese patients.
GID shares lost half their value earlier this year after the company revealed that the FDA halted enrollment in a U.S. clinical trial for EndoBarrier, after 4 patients developed bacterial infections known as hepatic abscesses. The company had already been struggling to overcome news late last year that European regulators had halted EndoBarrier sales there. Shipments resumed in December 2014 after the product’s labeling was modified to include certain prescribing restrictions, but GI Dynamics still laid off 10% of its workforce that month, including its longtime CFO.
CEO Stuart Randle stepped down in August 2014, succeeded by ex-ATS Medical chief Michael Dale.
In April of this year the company exercised a 1-for-10 reverse stock split to bolster its flagging stock price.
AxoGen marketing chief Schiaparelli jumps ship for mystery CEO role
AxoGen Inc. (NSDQ:AXGN) said last week that its chief marketing officer, Jill Schiaparelli, resigned to take the CEO spot at an unnamed life sciences company. Schiaparelli, who joined AxoGen in 2012, is a director at Intelomed.
Gamma Medica snags ex-LifeCell CEO Croxford
Gamma Medica said it replaced CEO Jim Calandra, who left to “pursue other opportunities,” with former LifeCell CEO Philip Croxford. The company also said it named Toshiba America Medical Systems vet Scott Headland as its new vice president of sales.
EndoGastric Solutions expands team
EndoGastric Solutions said it added 3 new names to its executive roster: former St. Jude Medical (NYSE:STJ) senior vice president Mike Zagger as VP of sales & marketing; Given Imaging vet Philip Macdonald as VP of healthcare economics, policy & reimbursement; and Dr. Adrian Lobontiu, who re-joined as medical director after a year away from the company.
Calhoun Vision taps LenSx co-founders Kurtz, Weinberg
Calhoun Vision said it named LenSx Lasers co-founders Dr. Ron Kurtz to be its new COO and Eric Weinberg as chief commercial officer. The company in March replaced former CEO Verne Sharma with Rick Heinick, a former Bausch & Lomb executive who helped lead the firm until its acquisition by Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) in 2013.